Commercial AI in Pharma: From Pilots to Performance
Build the data, CRM and governance foundations for the next commercial model.
Take a practical look at how pharma organizations can move from isolated pilots to scalable, governed, and performance-focused AI. Explore how commercial teams can redesign CRM, data, content, field engagement, compliance and operating models together, building the foundations needed for AI to become a trusted driver of commercial effectiveness.
Inside the Report: Top 5 Strategic Takeaways
- Move beyond AI pilots by embedding AI into governed commercial workflows that teams can trust and adopt.
- Turn CRM into a commercial intelligence layer that supports next-best action, customer targeting, field planning and omnichannel engagement.
- Improve HCP engagement with more relevant, timely and coordinated interactions across sales, marketing, medical and service channels.
- Design compliance into AI-enabled workflows from the start with clear thresholds, auditability, human accountability and continuous monitoring.
- Understand what it takes to scale AI across the commercial function with senior sponsorship, field adoption, compliance partnership and clear operating ownership.
Essential reading for: Senior pharmaceutical leaders shaping the future of pharmaceutical commercialization, marketing, medical affairs and digital & technology integration.
"Companies should shift more … to see how they can educate their existing workforce to use the technology effectively … because a lot of these things that other companies are building will become commoditized"
